AU2002337388A1 - Improvements in or relating to inhibition of viruses - Google Patents

Improvements in or relating to inhibition of viruses

Info

Publication number
AU2002337388A1
AU2002337388A1 AU2002337388A AU2002337388A AU2002337388A1 AU 2002337388 A1 AU2002337388 A1 AU 2002337388A1 AU 2002337388 A AU2002337388 A AU 2002337388A AU 2002337388 A AU2002337388 A AU 2002337388A AU 2002337388 A1 AU2002337388 A1 AU 2002337388A1
Authority
AU
Australia
Prior art keywords
viruses
inhibition
relating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002337388A
Other languages
English (en)
Inventor
Jamie Arnold
Jan Balzarini
Daniel Brown
Craig Cameron
Christian Castro
Jason Graci
Victoria Korneeva
David Loakes
Kei Moriyama
Kazuo Negishi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medical Research Council
Original Assignee
Medical Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0126701A external-priority patent/GB0126701D0/en
Application filed by Medical Research Council filed Critical Medical Research Council
Publication of AU2002337388A1 publication Critical patent/AU2002337388A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Saccharide Compounds (AREA)
AU2002337388A 2001-11-07 2002-11-07 Improvements in or relating to inhibition of viruses Abandoned AU2002337388A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0126701A GB0126701D0 (en) 2001-11-07 2001-11-07 Improvements in or relating to induction of mutations in viruses
GB0126701.2 2001-11-07
US10/207,005 US7049303B2 (en) 2001-11-07 2002-07-30 Inhibition of viruses
US10/207,005 2002-07-30
PCT/GB2002/005031 WO2003039450A2 (en) 2001-11-07 2002-11-07 Improvements in or relating to inhibition of viruses

Publications (1)

Publication Number Publication Date
AU2002337388A1 true AU2002337388A1 (en) 2003-05-19

Family

ID=26246745

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002337388A Abandoned AU2002337388A1 (en) 2001-11-07 2002-11-07 Improvements in or relating to inhibition of viruses

Country Status (5)

Country Link
US (2) US7049303B2 (https=)
EP (1) EP1441744A2 (https=)
JP (1) JP2005507944A (https=)
AU (1) AU2002337388A1 (https=)
WO (1) WO2003039450A2 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7094768B2 (en) * 2002-09-30 2006-08-22 Genelabs Technologies, Inc. Nucleoside derivatives for treating hepatitis C virus infection
AU2003279797B2 (en) * 2002-09-30 2009-10-22 Genelabs Technologies, Inc. Nucleoside derivatives for treating hepatitis C virus infection
EP1682564A1 (en) * 2003-10-27 2006-07-26 Genelabs Technologies, Inc. METHODS FOR PREPARING 7-(2 -SUBSTITUTED-s-D-RIBOFURANO SYL)-4-(NR2R3)-5-(SUBSTITUTED ETHYN-1-YL)-PYRROLO 2,3-D|PYRIMIDINE DERIVATIVES
KR101170925B1 (ko) 2004-06-18 2012-08-07 노바티스 백신즈 앤드 다이아그노스틱스 인코포레이티드 암 치료용 키네신 방추 단백질 (ｋｓｐ) 억제제로서의ｎ-(1-(1-벤질-4-페닐-1ｈ-이미다졸-2-일)-2,2-디메틸프로필)벤자미드 유도체 및 관련 화합물
EP1858889A1 (en) * 2005-03-08 2007-11-28 Biota Scientific Management Pty. Ltd. Bicyclic nucleosides and nucleotides as therapeutic agents
US8415321B2 (en) 2008-04-15 2013-04-09 Raymond F. Schinazi Nucleoside derivatives for treatment of Caliciviridae infections, including Norovirus infections
ES2540964T3 (es) 2009-06-08 2015-07-15 Takeda Pharmaceutical Company Limited Compuestos de dihidropirrolonaftiridinona como inhibidores de JAK
BR112015009636A8 (pt) * 2012-10-29 2018-04-17 Cocrystal Pharma Inc composto, métodos para o tratamento de um hospedeiro infectado, métodos para a prevenção de uma infecção, métodos para a redução da atividade biológica de uma infecção e uso de um composto
DK3236972T3 (en) 2014-12-26 2021-10-04 Univ Emory Antivirale N4-hydroxycytidin-derivativer
JP6804790B1 (ja) 2017-12-07 2020-12-23 エモリー ユニバーシティー Ｎ４−ヒドロキシシチジンおよび誘導体ならびにそれらに関連する抗ウイルス用途
WO2023152709A1 (en) * 2022-02-14 2023-08-17 Arbutus Biopharma Corporation Rna polymerase inhibitors and methods using same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8802687D0 (sv) 1988-07-20 1988-07-20 Astra Ab Nucleoside derivatives
EP0375183A1 (en) 1988-12-05 1990-06-27 Schering Corporation Antiviral dimers and trimers
DK62592D0 (https=) * 1992-05-14 1992-05-14 Novo Nordisk As
US5773424A (en) 1994-12-16 1998-06-30 Research Corporation Technologies, Inc. Treatment of toxoplasmosis
EP0831852B1 (en) 1995-06-07 2006-11-29 Emory University Nucleosides with anti-hepatitis b virus activity
ATE271063T1 (de) 1996-10-16 2004-07-15 Icn Pharmaceuticals Purin-l-nukleoside, deren analoga und verwendungen
EP0948256A4 (en) 1996-10-28 2007-10-24 Univ Washington INDUCTION OF VIRAL MUTATIONS BY INTRODUCTION TO ERROR-CODED RIBONUCLEOSIDE ANALOGUES IN VIRAL RNA
KR100719606B1 (ko) 1998-02-25 2007-05-17 에모리 유니버시티 2'-플루오로뉴클레오사이드
IL133680A0 (en) 1999-09-10 2001-04-30 Can Fite Technologies Ltd Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist
AU2603101A (en) 1999-12-22 2001-07-03 Inspire Pharmaceuticals, Inc. Method of treating gastrointestinal tract disease with purinergic receptor agonists

Also Published As

Publication number Publication date
EP1441744A2 (en) 2004-08-04
JP2005507944A (ja) 2005-03-24
US20050043268A1 (en) 2005-02-24
WO2003039450A3 (en) 2003-08-21
US7049303B2 (en) 2006-05-23
US20030130226A1 (en) 2003-07-10
WO2003039450A2 (en) 2003-05-15

Similar Documents

Publication Publication Date Title
AU2002237124B2 (en) Compositions and methods relating to osteoarthritis
IL158643A0 (en) Use of hmg fragments as anti-inflammatory agents
GB0107669D0 (en) Improvements relating to liver surgery
AU2001234837A1 (en) Azapeptides useful in the treatment of hepatitis c
AU2002337388A1 (en) Improvements in or relating to inhibition of viruses
AU2001227972A1 (en) Methods to treat alpha-1-antitrypsin deficiency
AU2001293048A1 (en) Antiviral compositions and methods of use
GB2373004B (en) Improvements in or relating to the protection of buildings
AU2002359792A1 (en) Methods and compositions for the inhibition of viral release
EP1439845A4 (en) INACTIVATION OF THE PAPILLOMA
WO2002083858A8 (en) Methods to inhibit viral replication
AU2002241162A1 (en) Intimins in the prevention or treatment of infections:ii
GB0100151D0 (en) Methods of sputtering
AU2001286052A1 (en) Improvements relating to water treatment
AU2002236439A1 (en) Purification of argon
AU2002323085A1 (en) Inhibition of viral replication by targeting rna-dna complexes
GB0118126D0 (en) Improvements in or relating to vapourisers
AU2002321556A1 (en) Inhibition of replication factor c
AU2002334068A1 (en) Improvements in or relating to detection of impaired fertility
HK1063638A (en) Methods to inhibit viral replication
GB0101480D0 (en) Improvements and or relating to organic compositions
GB0122499D0 (en) Improvements in or relating to the removal of chemicals
AU2002231976A1 (en) Improvements relating to the protection of buildings
AUPR788001A0 (en) Further improvements in the removal of phosphate from water
HK1064126A (en) Use of hmg fragments as anti-inflammatory agents

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase